Inhibition of LTP by beta-amyloid is prevented by activation of β2 adrenoceptors and stimulation of the cAMP/PKA signalling pathway

Neurobiology of Aging

Volumn 30, Issue 10, 2009, Pages 1608-1613

  Wang, Qin wen ^a,b   Rowan, Michael J ^a   Anwyl, Roger ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b NINGBO UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Beta amyloid; Hippocampus; LTP; Noradrenaline; PKA

Indexed keywords

AMYLOID BETA PROTEIN; BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FORSKOLIN;

ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DENTATE GYRUS; ENZYME ACTIVATION; LONG TERM POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADENYLATE CYCLASE; ADRENERGIC AGENTS; AMYLOID BETA-PROTEIN; ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DENTATE GYRUS; DOBUTAMINE; ENZYME INHIBITORS; FORSKOLIN; LONG-TERM POTENTIATION; MALE; PROPANOLAMINES; RATS; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION; TERBUTALINE; THIONUCLEOTIDES;

EID: 69249202594     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.12.004     Document Type: Article

References (33)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
2. Bamberger M.E., Harris M.E., McDonald D.R., Husemann J., and Landreth G.E. A cell surface receptor complex for fibrillar β-amyloid mediates microglial activation. J. Neurosci. 23 (2003) 2665-2674
3. Bondareff W., Mountjoy C.O., Roth M., Rossor M.N., Iversen L.L., Reynolds G.P., and Hauser D.L. Neuronal degeneration in locus coeruleus and cortical correlates of Alzheimers disease. Alzheimer Dis. Assoc. Disord. 1 (1987) 256-262
4. Colton C.A., and Chernyshev O.N. Inhibition of microglial superoxide anion production by isoproterenol and dexamethasone. Neurochem. Int. 29 (1996) 43-53
5. Combs C.K., Johnson D.J., Cannady S.B., Lehman T.M., and Landreth G.E. Inflammatory mechanism in Alzheimers disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR-gamma agonist. J. Neurosci. 21 (2000) 1179-1181
6. Cotman C.W., and Su J.H. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol. 4 (1996) 493-506
7. Cullen W.K., Suh Y.H., Anwyl R., and Rowan M.J. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. Neuroreport 8 (1997) 3213-3217
8. Dello Rosso C., Boullerne A.I., Gavrilyuk V., and Feinstein D.L. Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin 1beta production. J. Neuroinflamm. 1 (2004) 11-19
9. Eikelenboom P., Zahn S.S., van Gool W.A., and Allsop D. Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol. Sci. 15 (1994) 447-450
10. Feinstein D.L. Suppression of astroglial nitric oxide synthase expression by norepinephrine results from decreased NOS-2 promoter activity. J. Neurochem. 70 (1998) 1484-1496
11. Feinstein D.L., Heneka M.T., Gavrilyuk V., Dello Russo C., Weinberg G., and Galea E. Noradrenergic regulation of inflammatory gene expression in brain. Neurochem. Int. 41 (2002) 357-365
12. Fujita H., Tanaka J., Maeda N., and Sakanaka M. Adrenergic agonists suppress the proliferation of microglia through β2 adrenergic receptor. Neurosci. Lett. 242 (1996) 37-40
13. German D.C., Manaye K.F., White III C.L., Woodward D.J., McIntire D.D., Smith W.K., Kalaria R.N., and Mann D.M. Disease-specific patterns of locus coeruleus cell loss. Ann. Neurol. 32 (1992) 667-676
14. Griffin W.S., Sheng J.C., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., and Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: the potential role of a cytokine cycle in disease progression. Brain Pathol. 8 (1998) 65-72
15. Heneka M.T., Galea E., Gavriluyk V., Dumitrescu-Ozimek L., Daeschner J., O'Banion M.K., Weinberg G., Klockgether T., and Feinstein D.L. Noradrenergic depletion potentiates beta-amyloid-induced cortical inflammation: implications for Alzheimer's disease. J. Neurosci. 22 (2002) 2434-2442
16. Hu X.X., Goldmuntz E.A., and Brosnan C.F. The effect of norepinephrine on endotoxin-mediated macrophage activation. J. Neuroimmunol. 31 (1991) 35-42
17. Kalinin S., Gavrilyuk V., Polak P.E., Heneka M.T., and Feinstein D.L. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimers disease. Neurobiol. Aging 28 (2007) 1206-1214
18. 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. 95 (1998) 6448-6453
19. MacKenzie I.R., and Munoz D.G. Nonsteroidal anti-inflammatory use and Alzheimer-type pathology in ageing. Neurology 50 (1998) 986-990
20. Madrigal J.L., Feinstein D.L., and Dello Russo C. Norepinephrine protects cortical neurons against microglial induced cell death. J. Neurosci. Res. 81 (2005) 390-396
21. McGeer P.L., and McGeer E.G. The inflammatory response system of the brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21 (1995) 195-218
22. Mori K., Ozaki E., Zhang B., Yang L., Yokoyama A., Takeda I., Maeda N., Sakanaka M., and Tanaka J. Effects of norepinephrine on rat cultured microglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors. Neuropharmacology 43 (2002) 1026-1034
23. Small D.H., Mok S.S., and Bornstein J.C. Alzheimer's disease and Abeta toxicity: from top to bottom. Nat. Rev. Neurosci. 8 (2002) 595-598
24. Stanton P.K., and Sarvey J.M. Norepinephrine regulates long-term potentiation of both the population spike and dendritic EPSP in hippocampal dentate gyrus. Brain Res. Bull. 18 (1987) 115-119
25. Tan J., et al. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 286 (1999) 2352-2355
26. Vitolo O.V., Sant'Angelo A., Costanzo V., Battaglia F., Arancio O., and Shelanski M. Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl. Acad. Sci. 99 (2002) 13217-13221
27. Walsh D.M., Klyubuin I., Fadeeva J., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of the Alzheimer amyloid β-protein potently inhibit long-term potentiation in vivo. Nature 416 (2002) 535-539
28. Wang Q., Walsh D.M., Rowan M.J., Selkoe D.J., and Anwyl R. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 24 (2004) 3370-3378
29. Wang Q., Rowan M.J., and Anwyl R. Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide. J. Neurosci. 24 (2004) 6049-6056
30. Wang Q., Wu J., Rowan M.J., and Anwyl R. Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor. Eur. J. Neurosci. 22 (2005) 2827-2832
31. Willis S.A., and Nisen P.D. Inhibition of lipopolysaccharide-induced IL-1 beta transcription by cyclic adenosine monophosphate in human astrocytic cells. J. Immunol. 154 (1995) 1399-1406
32. Winder D.G., Martin K.C., Muzzio I.A., Rohrer D., Chruscinski A., Kobilka B., and Kandel E.R. ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by beta-adrenergic receptors. Neuron 24 (1999) 715-726
33. Wu J., Rowan M.J., and Anwyl R. Long-term potentiation is mediated by multiple kinase cascades involving CAMKII or p42/44 MAPK in the adult rat dentate gyrus in vitro. Neurophysiol 95 (2006) 3519-3527